R-Biopharm AG is one of Germany’s leading biotechnology companies
0
Foundation
0
Employees worldwide
0
Countries and distributors
0
Subsidiaries
The family business, managed by the second generation, sees itself as a pioneer for health and quality of life. With excellent solutions from its three business units food and feed analysis, nutrition care and clinical diagnostics, it aims to provide precision, safety and certainty – in prevention, therapy and healing. R-Biopharm is an internationally recognized suppier and the world market leader in test systems for allergen analysis and combines development, production and sales under one roof. R-Biopharm is multiple winner of the “Sustainability Award“ for sustainable and profitable growth.
Photo material for free use with the source reference “R-Biopharm AG”:
The two CEOs seal the partnership between R-Biopharm and AusDiagnostics with a handshake: Christian Dreher (right, R-Biopharm) and Scott Gilroy (AusDx).
The swab is safely locked for transportation from the corona rapid testing center Darmstadt to humatrix AG which analyzes the samples in its laboratory.
Dr. Anna Carina Eichhorn, managing director of humatrix AG, visits the corona rapid testing center Darmstadt with Christian Dreher, CEO of R-Biopharm AG.
Within 20 minutes the test strips of the rapid test RIDA®QUICK SARS-CoV-2 Antigen by R-Biopharm indicate if an infection with the corona virus is present.
Dr. Anna Carina Eichhorn, managing director of humatrix AG, with the corona rapid test RIDA®QUICK SARS-CoV-2 Antigen by R-Biopharm which is used to examine the samples of the rapid test center in Pfungstadt.
SAFE School Hessen Studie examined the practical suitability of the SARS-CoV-2 Antigen rapid test for self-use – with the participation of 600 Hessian teachers.
The Hessian Minister for Social Affairs and Integration Kai Klose (right) visits R-Biopharm for the presentation of the antigen rapid test in context of the study “Safe School Hessen“. Here talking to CEO Christian Dreher.
The Hessian Minister for Social Affairs and Integration Kai Klose (right) and the virologist from Frankfurt Sandra Ciesek visit R-Biopharm for a presentation of the antigen rapid test.
The Hessian Minister for Social Affairs and Integration Kai Klose (right) and the virologist from Frankfurt Sandra Ciesek listen to an explanation of the antigen rapid test during their visit at R-Biopharm.
The Hessian Minister for Social Affairs and Integration Kai Klose (left) and the virologist Sandra Ciesek during a tour through R-Biopharm guided by CEO Christian Dreher (right)